Avantor, Inc. (AVTR)
15.53
-0.09
(-0.58%)
USD |
NYSE |
Nov 13, 16:00
15.53
0.00 (0.00%)
After-Hours: 19:59
Avantor Market Cap : 10.52B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 10.59B |
| November 11, 2026 | 10.66B |
| November 10, 2026 | 10.55B |
| November 09, 2026 | 10.78B |
| November 06, 2026 | 10.48B |
| November 05, 2026 | 10.26B |
| November 04, 2026 | 10.61B |
| November 03, 2026 | 10.57B |
| November 02, 2026 | 10.58B |
| October 30, 2026 | 10.88B |
| October 29, 2026 | 11.30B |
| October 28, 2026 | 11.31B |
| October 27, 2026 | 11.61B |
| October 26, 2026 | 11.72B |
| October 23, 2026 | 11.72B |
| October 22, 2026 | 11.60B |
| October 21, 2026 | 11.68B |
| October 20, 2026 | 11.24B |
| October 19, 2026 | 11.02B |
| October 16, 2026 | 11.11B |
| October 15, 2026 | 10.88B |
| October 14, 2026 | 10.62B |
| October 13, 2026 | 10.52B |
| October 12, 2026 | 10.48B |
| October 09, 2026 | 10.60B |
| Date | Value |
|---|---|
| October 08, 2026 | 10.41B |
| October 07, 2026 | 10.38B |
| October 06, 2026 | 10.44B |
| October 05, 2026 | 10.70B |
| October 02, 2026 | 10.38B |
| October 01, 2026 | 10.17B |
| September 30, 2026 | 10.18B |
| September 29, 2026 | 10.31B |
| September 28, 2026 | 10.34B |
| September 25, 2026 | 10.32B |
| September 24, 2026 | 10.40B |
| September 23, 2026 | 9.985B |
| September 22, 2026 | 10.11B |
| September 21, 2026 | 10.22B |
| September 18, 2026 | 10.50B |
| September 17, 2026 | 10.73B |
| September 16, 2026 | 10.56B |
| September 15, 2026 | 10.45B |
| September 14, 2026 | 10.26B |
| September 11, 2026 | 10.02B |
| September 10, 2026 | 10.07B |
| September 09, 2026 | 10.07B |
| September 08, 2026 | 10.32B |
| September 04, 2026 | 10.13B |
| September 03, 2026 | 10.28B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Champions Oncology, Inc. | 65.14M |
| Medpace Holdings, Inc. | 18.23B |
| Personalis, Inc. | 1.702B |
| Adaptive Biotechnologies Corp. | 4.692B |
| 10X Genomics, Inc. | 7.650B |
Market Cap Related Metrics
| PE Ratio | 31.30 |
| PS Ratio | 1.588 |
| Price to Book Value | 1.803 |
| Price to Free Cash Flow | 23.99 |
| Price | 15.53 |
| Earnings Yield | 3.19% |
| Operating PE Ratio | 19.21 |
| Normalized PE Ratio | 28.06 |